Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Kristy Lee

3PUBLICATIONS

22CO-AUTHORS

Liquid biopsiesGene expression (incl. microarray and other genome-wide approaches)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Mar 18, 2025

How people undergoing genomic sequencing interpret and react to varied secondary findings with limited actionability.

Haoyang Yan, Christine M Rini, Ann Katherine M Foreman

|Apr 29, 2016

A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation.

Jessica Ezzell Hunter, Stephanie A Irving, Leslie G Biesecker

|Aug 14, 2015

A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing.

Jonathan S Berg, Ann Katherine M Foreman, Julianne M O'Daniel

Pageof 1

Frequent Collaborators

3 joint publications

Jonathan S Berg

3 joint publications

Julianne O'Daniel

2 joint publications

Myra Roche

1 joint publications

Kristy R Crooks

1 joint publications

Bradford C Powell

1 joint publications

Cynthia M Powell

1 joint publications

Natasha T Strande

1 joint publications

Jessica Ezzell Hunter

1 joint publications

Adam Buchanan

1 joint publications

Kristin Muessig

Frequent Collaborators

3 joint publications

Jonathan S Berg

3 joint publications

Julianne O'Daniel

2 joint publications

Myra Roche

1 joint publications

Kristy R Crooks

Top Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on : Apr 04, 2018

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on : Jan 16, 2019

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on : Aug 21, 2016

See more related videos

Top Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on : Apr 04, 2018

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on : Jan 16, 2019

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on : Aug 21, 2016

See more related videos